Jessica McCabe tell us the story of her life. A gifted child, she was once destined for great things, but her ADHD diagnosis later made her a failure. One thing changed everything, and she discovered that she was not the only one. YouTube channel HowtoADHD was created to assist people with ADHD and their families, teachers, and partners.
Jessica McCabe nam rozprava pribeh svojho zivota. Kedysi nadane dieta so ziarivou buducnostou, ktore neskor zije zivot plny neustalych neuspechov, len kvoli jednej veci – jej ADHD diagnoze. Az do momentu kedy sa vsetko zmeni a ona si uvedomi, ze v tom nie je sama. Jej YouTube kanal HowtoADHD je venovany pomoci a usmernovaniu nielen ludi s ADHD ale takisto aj ich rodicom, partnerom a ucitelom a takisto aj odkazu, ze v tom nie su nikdy sami. Jessica is the creator of the YouTube series How to ADHD. It focuses on supporting ADHD brains all over the globe. This talk was delivered at a TEDx event that used the TED conference format, but was independently organized by a local community. Find out more at x
https://adhdadulttreatment.com/failing-at-normal-an-adhd-success-story-jessica-mccabe-tedxbratislava/
Happy ADHD Awareness Month! In honor of that, and hitting half a million subscribers (eeee!!!), I decided to ask Dr. Carolyn Lentzch-Parcells (www.gtw-health.com) to come talk about stimulant medication -- and help bust some of the stigma that keeps people from treating their ADHD.
#ADHD #treatment #stigma
-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=
Facebook: d
Twitter: d
Support us on Patreon: d
WE WROTE A SONG!!
Get the “The Fish Song” on...
...iTunes: s
...Google Music: p
...Amazon: n
LINKS:
/>
References
The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment
strategies for attention-deficit/hyperactivity disorder (ADHD). Arch Gen
Psychiatry 1999;56: 1073-1086.
Molina BSG, Hinshaw S.P., Swanson J.M., Arnold, L.E., Vitiello B, Jensen PS, Epstein
JN, Hoza B, Hechtman L., Abikoff, H.B., Elliott GR, Greenhill LL, Newcorn, JH, Wells
KC, Wigal TL, Severe JB, Gibbons RD, Hur K, Houck PR, and the MTA Cooperative
Group: The MTA at 8 years: prospective follow-up of children treated for
combined type ADHD in a multisite study. J Am Acad Child Adolesc
Psychiatry 2009;48: 484-500.
Barbaresi, William J. MD (Guideline Panel Chair) ; Campbell, Lisa MD † ; Diekroger, Elizabeth A. MD ‡ ;
Froehlich, Tanya E. MD § ; Liu, Yi Hui MD, MPH ‖ ; O'Malley, Eva ¶ ; Pelham, William E. Jr PhD, ABPP ;
Power, Thomas J. PhD, ABPP †† ; Zinner, Samuel H. MD ‡‡ ; Chan, Eugenia MD, MPH Society for
Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and
Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity
Disorder, Journal of Developmental & Behavioral Pediatrics: February/March 2020 - Volume 41 -
Issue - p S35-S57 doi: 10.1097/DBP.0000000000000770
Krull, Kevin. Pharmacology of drugs used to treat attention deficit hyperactivity disorder in
children and adolescents. UpToDate: February 2020.
Wolraich, Mark L, Joseph F. Hagan Jr, Carla Allan, Eugenia Chan, Dale Davison,
Marian Earls, Steven W. Evans, Suan K. Flinn, Tanya Froehlish, Jennifer Frost, Joseph
R. Holbrook, Christoph Ulrich Lehmann, Herschel Robert Lessin, Kymika, Okechukwu,
Karen L Pierce, Jonathan D. Winner, William Zurhellen and SUBCOMMITTEE ON
CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE
DISORDER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of
Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019;
144; DOI: 10.1542/peds.2019-2528.
Barkley RA, Fischer M. Hyperactive Child Syndrome and Estimated Life Expectancy at
Young Adult Follow-Up: The Role of ADHD Persistence and Other Potential Predictors.
J Atten Disord. 2019 Jul;23(9): 907-923. doi: 10.1177/1087054718816164. Epub 2018
Dec 10. PMID: 30526189.
/
/
Music for "Why Stimulant Medication is Used to Treat ADHD (& why we feel weird about it)"
"The Show Must Be Go” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0
/
No comments:
Post a Comment